Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

QNext and DG-PT

K-Number: K183390 · 2019-08-21

Decision Date2019-08-21
Product CodeJPA
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

QNext and DG-PT is the device name listed in this FDA 510(k) record. The listed applicant is Diagnostic Grifols, S.A.. It received FDA 510(k) clearance on 2019-08-21 under 510(k) number K183390. The device is classified under product code JPA. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the QNext and DG-PT?

QNext and DG-PT is a medical device that received FDA 510(k) clearance on 2019-08-21. The listed applicant is Diagnostic Grifols, S.A.. The 510(k) number is K183390.

When did QNext and DG-PT receive FDA 510(k) clearance?

QNext and DG-PT received FDA 510(k) clearance on 2019-08-21, under 510(k) number K183390.

Who is the listed applicant for QNext and DG-PT?

The FDA 510(k) record lists Diagnostic Grifols, S.A. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for QNext and DG-PT?

The FDA product code for QNext and DG-PT is JPA.

Related Devices (Code: JPA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.